Halozyme Therapeutics, Inc. (HALO) Earnings
NASDAQ·Healthcare·Biotechnology
$111.66
+1.81%
Mkt Cap $12.72B
EPS — Estimate vs Actual
Mkt Cap
$12.72B
P/E
43.91
Fwd P/E
7.47
P/S
9.10
Rev TTM
—
EPS TTM
$2.49
NASDAQ·Healthcare·Biotechnology
$111.66
+1.81%
Mkt Cap $12.72B
Mkt Cap
$12.72B
P/E
43.91
Fwd P/E
7.47
P/S
9.10
Rev TTM
—
EPS TTM
$2.49